The designs came from internal generative AI models and the renders came from standard display tools with our own customisations.

We are committed to developing our models responsibly and to a continuous evaluation of our model’s capabilities, risks and limitations. We have been participating in conversations with governmental organizations and biosafety experts, and are looking to support biosafety research.

We use our lab to validate our models’ capabilities and to generate data for a variety of purposes.

We are empowering partners in developing therapeutic molecules. Internally we are designing biomolecules for R&D purposes such as validating our models and generating data.

Latent Labs’ technology can be applied beyond drug discovery.

Controlling the characteristics of biomolecules allows optimization for critical requirements of all stages of the drug discovery process, including stages far downstream.

For partnership and collaboration requests please reach out to contact@latentlabs.com.

We are building our own generative AI models and run wet lab facilities in San Francisco.